Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Privi Speciality Chemicals's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 3,169.82 | 2,790.51 | 2,342.55 |
| Accumulated Depreciation Total | -919.88 | -779.66 | -648.83 |
| Cash Equivalents | 27.97 | 0.09 | 0.09 |
| Other Liabilities Total | 33.23 | 24.51 | 19.15 |
| Accrued Expenses | 48.82 | 27.74 | 13.58 |
| Long Term Debt | 577.9 | 511.13 | 444.5 |
| Common Stock Total | 39.06 | 39.06 | 39.06 |
| Other Equity Total | 7.55 | 5.02 | 4.35 |
| Other Current Assets Total | 25.44 | 0.43 | 4.8 |
| Prepaid Expenses | 10.57 | 8.67 | 8.35 |
| Total Assets | 3,169.82 | 2,790.51 | 2,342.55 |
| Current Portof LT Debt/Capital Leases | 115.09 | 141.64 | 146.09 |
| Cash | 16.13 | 49.67 | 23.9 |
| Total Equity | 1,412.43 | 1,103.43 | 924.39 |
| Long Term Investments | 0.91 | 0.83 | 0.76 |
| Retained Earnings(Accumulated Deficit) | 1,365.82 | 1,059.35 | 880.98 |
| Total Common Shares Outstanding | 3.91 | 3.91 | 3.91 |
| Property/Plant/Equipment Total-Gross | 2,378.6 | 2,052.51 | 1,762 |
| Tangible Book Valueper Share Common Eq | 355.55 | 276.2 | 231.51 |
| Total Liabilities | 1,757.39 | 1,687.08 | 1,418.16 |
| Total Debt | 987.72 | 1,126.24 | 1,004.58 |
| Short Term Investments | 53.59 | 7.54 | 39.56 |
| Cashand Short Term Investments | 97.68 | 57.3 | 63.55 |
| Total Receivables Net | 583.4 | 472.2 | 384.01 |
| Notes Payable/Short Term Debt | 292.02 | 464 | 395.45 |
| Deferred Income Tax | 22.69 | 24.11 | 23.2 |
| Accounts Receivable-Trade Net | 526.01 | 394.15 | 347.5 |
| Property/Plant/Equipment Total-Net | 1,458.71 | 1,272.85 | 1,113.18 |
| Minority Interest | 28.17 | 14.49 | 16.74 |
| Total Current Liabilities | 1,092.69 | 1,103.37 | 896.04 |
| Total Inventory | 878.82 | 824.69 | 681.12 |
| Accounts Payable | 527.42 | 402.25 | 282.51 |
| Other Currentliabilities Total | 109.34 | 67.74 | 58.4 |
| Total Long Term Debt | 580.6 | 520.6 | 463.04 |
| Intangibles Net | 23.56 | 24.51 | 20.06 |
| Other Long Term Assets Total | 23.44 | 60 | 22.71 |
| Note Receivable-Long Term | 67.29 | 69.02 | 44 |
| Total Current Assets | 1,595.91 | 1,363.3 | 1,141.84 |
| Capital Lease Obligations | 2.7 | 9.46 | 18.54 |
PEG Ratio0.28
Price to Sale Ratio5.57
Debt 5Yr CAGR %12.98
Operating Margin 12m19.52
Operating Margin 5y Avg13.04
Net Profit Margin 12m12.8
Net Profit Margin 5y7.59
Dividend Yield %0.27
Overall RiskBalanced risk
Board Risk30.15
ConsensusStrong Buy
Consensus score1.50
Analyst opinions2
Strong Sell count0
Sell count0
Hold count0
Buy count1
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,749 | 2.64 L | 58.09 | — |
| Solar Industries India | INR 18,560 | 1.68 L | 99.61 | — |
| Pidilite Industries | INR 1,671 | 1.70 L | 64.76 | — |
| SRF | INR 2,626 | 77,841.16 | 44.57 | — |
| Linde India | INR 7,105 | 61,033.66 | 110.53 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Price to earnings forward of Privi Speciality Chemicals Limited – NSE:PRIVISCL TradingView
Privi Speciality Chemicals Plans ₹1,250 Crore Expansion Whalesbook
Broker’s Call: Privi Speciality Chem (Add) BusinessLine
Privi Speciality Chemicals FY26 PAT surges 75% to INR 327.54 Crores scanx.trade
Privi Speciality Chemicals Ltd is Rated Buy MarketsMojo
Specialty Chemical Stock to Buy Now for 30% Upside Potential Trade Brains
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Privi Speciality Chemicals Limited is an India-based manufacturer, supplier and exporter of aroma and fragrance chemicals. The Company's flagship products include Dihydromyrcenol, Amber Fleur, Pine oil and Terpineol, Camphor, Speciality, Citral, Prionyl, Ionone products, OTBCHA, PTBCHA, Galaxmusk, Indomerane, and Floravone. It also develops and produces custom-made aroma chemicals as per the specific requirements of the customers. Its products are used in personal care items, household cleaners, and fine fragrances. The Company's manufacturing units are located at Mahad, Maharashtra and Jhagadia, Gujarat. The Company has a total production capacity of over 48,000 million tons per annum (MTPA) and Crude Sulphate Turpentine (CST) over 36,000 TPA. The Company’s subsidiaries include Privi Biotechnologies Private Limited, Privi Speciality Chemicals USA Corporation and Prigiv Specialties Private Limited.
Privi Speciality Chemicals has the symbol PRIVISCL and ISIN - INE959A01019.
Privi Speciality Chemicals is currently trading at INR 3,452.50.
Privi Speciality Chemicals has a year high of INR 3,785.30 and a year low of INR 2,281.10.
Privi Speciality Chemicals has a market capitalization of INR 14,269.52 crore.
Privi Speciality Chemicals has a P/E ratio of 41.00.
Privi Speciality Chemicals has a dividend yield of 0.27%.
Privi Speciality Chemicals has revenue of INR 2,563.69 crore, net income of INR 327.54 crore, and EPS of INR 89.56.
Privi Speciality Chemicals has a book value of NA.
Privi Speciality Chemicals has a debt-to-equity ratio of NA.
Privi Speciality Chemicals has a price-to-book ratio of NA and a price-to-sales ratio of 5.57.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.